Research programme: FGF-2 cancer vaccine - EntreMedAlternative Names: ENMD-0996
Latest Information Update: 19 Dec 2008
At a glance
- Originator EntreMed
- Class Cancer vaccines
- Mechanism of Action Angiogenesis inhibitors; Fibroblast growth factor inhibitors; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer